AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29871023 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 612
Study 27290985 — intervention group
Group type: EXPERIMENTAL
Intervention: RSGB group (lidocaine 1% 7 ml under ultrasound guidance)
Number of subjects: 80
Study 27290985 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 80
Study 24898466 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-centered meditation
Number of subjects: 44
Study 24898466 — intervention group
Group type: COMPARATOR
Intervention: Conventional morning walk
Number of subjects: 44
Study 21551421 — intervention group
Group type: EXPERIMENTAL
Intervention: PILI Lifestyle Program (PLP)
Number of subjects: 144
Study 21551421 — intervention group
Group type: COMPARATOR
Intervention: Standard Behavioral Program (SBP)
Number of subjects: 144
Study 19222821 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Test (RDT) before treatment decision
Number of subjects: 2169
Study 19222821 — intervention group
Group type: COMPARATOR
Intervention: Clinical management (presumptive treatment)
Number of subjects: 2169
Study 19222821 — intervention group
Group type: EXPERIMENTAL
Intervention: RDT positive patients (rainy season)
Number of subjects: 2169
Study 19222821 — intervention group
Group type: EXPERIMENTAL
Intervention: RDT negative patients (rainy season)
Number of subjects: 2169
Study 17785084 — intervention group
Group type: EXPERIMENTAL
Intervention: Low current group (Group A, n = 118)
Number of subjects: 188
Study 17785084 — intervention group
Group type: COMPARATOR
Intervention: Regular current group (Group B, n = 70)
Number of subjects: 188
Study 17785084 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior subgroup of Group A
Number of subjects: 188
Study 17785084 — intervention group
Group type: COMPARATOR
Intervention: Posterior subgroup of Group B
Number of subjects: 188
Study 15123534 — intervention group
Group type: EXPERIMENTAL
Intervention: LVAD placement
Number of subjects: 129
Study 15123534 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 129
Study 11593318 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI/CY/E
Number of subjects: 351
Study 11593318 — intervention group
Group type: COMPARATOR
Intervention: Bu/Mel/T
Number of subjects: 351
Study 11593318 — intervention group
Group type: COMPARATOR
Intervention: Bu/Mel/T (for patients with prior dose-limiting radiation)
Number of subjects: 351
Study 11593318 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI/CY/E and Bu/Mel/T
Number of subjects: 351
Study 9828916 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) replacement therapy
Number of subjects: 31
Study 9828916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 8106787 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg over 48 h)
Number of subjects: 130
Study 8106787 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine plus Clindamycin (5 mg/kg every 12 h for 6 doses)
Number of subjects: 130
Study 8106787 — intervention group
Group type: COMPARATOR
Intervention: Quinine (12 mg/kg every 12 h for 6 doses)
Number of subjects: 130
Study 8106787 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine plus Clindamycin (5 mg/kg every 12 h for 6 doses)
Number of subjects: 130
Study 2631854 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation A
Number of subjects: 12
Study 2631854 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation B
Number of subjects: 12
Study 2631854 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation C
Number of subjects: 12
Study 1139857 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial carbamazepine tablets
Number of subjects: 6
Study 1139857 — intervention group
Group type: COMPARATOR
Intervention: Propylene glycol solution
Number of subjects: 6
Study 31691831 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic tones delivered on the up phase of the slow-wave (STIM)
Number of subjects: 24
Study 31691831 — intervention group
Group type: COMPARATOR
Intervention: Inaudible 'tones' during equivalent periods of stimulation (SHAM)
Number of subjects: 24
Study 31118491 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose helical CT (LDCT) screening
Number of subjects: 0
Study 29219126 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritious meals provided through centralized kitchens
Number of subjects: 0
Study 29219126 — intervention group
Group type: COMPARATOR
Intervention: Regular meals from control kitchens
Number of subjects: 0
Study 26068624 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift (PUL) procedure
Number of subjects: 206
Study 26068624 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 206
Study 23601084 — intervention group
Group type: EXPERIMENTAL
Intervention: TM38837 500 mg
Number of subjects: 24
Study 23601084 — intervention group
Group type: EXPERIMENTAL
Intervention: TM38837 100 mg
Number of subjects: 24
Study 23601084 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimonabant 60 mg
Number of subjects: 24
Study 23601084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21757931 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg
Number of subjects: 60
Study 19369137 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (morning shift, individualized vaccination with reference nurse)
Number of subjects: 0
Study 19369137 — intervention group
Group type: COMPARATOR
Intervention: Control group (afternoon shift, vaccination as in previous years)
Number of subjects: 0
Study 16364329 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15605935 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic leg brace
Number of subjects: 31
Study 11318504 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of palm and soybean oils (PS)
Number of subjects: 10
Study 11318504 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmstearin and soybean oils (PSS)
Number of subjects: 10
Study 11318504 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oil (P)
Number of subjects: 10
Study 11318504 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmolein and soybean oils (POS)
Number of subjects: 10
Study 9209174 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (15 g/d)
Number of subjects: 0
Study 9209174 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (9 g/d)
Number of subjects: 0
Study 9209174 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 0
Study 9209174 — intervention group
Group type: COMPARATOR
Intervention: Vegetable oil (safflower oil)
Number of subjects: 0
Study 7758184 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 55
Study 7758184 — intervention group
Group type: COMPARATOR
Intervention: Control (untrained group)
Number of subjects: 55
Study 2225519 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundus body positioning of pH electrode
Number of subjects: 22
Study 2225519 — intervention group
Group type: COMPARATOR
Intervention: Identical diet on two different days
Number of subjects: 22
Study 2225519 — intervention group
Group type: COMPARATOR
Intervention: Variations of carbohydrate, protein, and fat content of isocaloric meals
Number of subjects: 22
Study 453272 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniocentesis
Number of subjects: 180
Study 453272 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin challenge tests (OCT's)
Number of subjects: 180
Study 453272 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labor after discovery of meconium
Number of subjects: 180
Study 31420830 — intervention group
Group type: EXPERIMENTAL
Intervention: metabolic gastric bypass (mRYGB)
Number of subjects: 45
Study 31420830 — intervention group
Group type: COMPARATOR
Intervention: sleeve gastrectomy (SG)
Number of subjects: 45
Study 31420830 — intervention group
Group type: COMPARATOR
Intervention: greater curvature plication (GCP)
Number of subjects: 45
Study 30928162 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening Arm (SA)
Number of subjects: 14136
Study 30928162 — intervention group
Group type: COMPARATOR
Intervention: Control Arm (CA)
Number of subjects: 14136
Study 28922651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch + nicotine lozenge
Number of subjects: 1504
Study 28922651 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion + nicotine lozenge
Number of subjects: 1504
Study 28922651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine lozenge
Number of subjects: 1504
Study 28922651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 1504
Study 28671098 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted approach
Number of subjects: 246
Study 28671098 — intervention group
Group type: COMPARATOR
Intervention: Open approach
Number of subjects: 246
Study 23674879 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical adhesive spray (group A)
Number of subjects: 171
Study 23674879 — intervention group
Group type: COMPARATOR
Intervention: Routine wound management (group B)
Number of subjects: 171
Study 21852283 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-Linked Computer-based Long-term Interactive Fitness Trainer (n = 52)
Number of subjects: 103
Study 21852283 — intervention group
Group type: COMPARATOR
Intervention: Attention control (n = 51)
Number of subjects: 103
Study 19151274 — intervention group
Group type: EXPERIMENTAL
Intervention: Indicated preoperative testing (complete blood count, electrolytes, blood glucose, creatinine, electrocardiogram, chest radiograph)
Number of subjects: 1061
Study 19151274 — intervention group
Group type: COMPARATOR
Intervention: No preoperative testing
Number of subjects: 1061
Study 15519184 — intervention group
Group type: EXPERIMENTAL
Intervention: Carmeda-coated oxygenators (BPS)
Number of subjects: 71
Study 15519184 — intervention group
Group type: EXPERIMENTAL
Intervention: Trillium-coated oxygenators (BAS)
Number of subjects: 71
Study 15519184 — intervention group
Group type: COMPARATOR
Intervention: Non-coated oxygenators (UMS)
Number of subjects: 71
Study 15519184 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (UMS, BPS, BAS)
Number of subjects: 71
Study 11343664 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin, enoxaparin, or reviparin for at least 4 days, plus a coumarin derivative with a target INR of 2.0 to 3.0 starting on the 1st or 2nd day of treatment.
Number of subjects: 1149
Study 11343664 — intervention group
Group type: EXPERIMENTAL
Intervention: Iliofemoral vein thrombosis
Number of subjects: 1149
Study 11343664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer
Number of subjects: 1149
Study 8860284 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention communities
Number of subjects: 22
Study 8860284 — intervention group
Group type: COMPARATOR
Intervention: Comparison communities
Number of subjects: 22
Study 1495357 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin/5-FU) followed by definitive radiation (6600 to 7600 cGy)
Number of subjects: 46
Study 6439026 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt
Number of subjects: 9
Study 6439026 — intervention group
Group type: COMPARATOR
Intervention: Pasteurized yogurt
Number of subjects: 9
Study 6439026 — intervention group
Group type: COMPARATOR
Intervention: Cultured milk (buttermilk)
Number of subjects: 9
Study 6439026 — intervention group
Group type: COMPARATOR
Intervention: Sweet acidophilus milk
Number of subjects: 9
Study 31174584 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 168
Study 31174584 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (historical cohort)
Number of subjects: 168
Study 29797908 — intervention group
Group type: EXPERIMENTAL
Intervention: Governor vessel daoqi method of acupuncture combined with estazolam (2 mg, taken 30 min before sleeping)
Number of subjects: 70
Study 29797908 — intervention group
Group type: COMPARATOR
Intervention: Estazolam alone (2 mg, taken 30 min before sleeping)
Number of subjects: 70
Study 27075687 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime transcutaneous electrical stimulation of the genioglossus muscle
Number of subjects: 38
Study 27075687 — intervention group
Group type: COMPARATOR
Intervention: Standard continuous positive airway pressure (CPAP) therapy
Number of subjects: 38
Study 24132806 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-laryngoscopy using a custom device (USB endoscopic camera, Macintosh laryngoscope blade, personal computer)
Number of subjects: 24
Study 24132806 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-laryngoscopy using a custom device
Number of subjects: 24
Study 22674708 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 553
Study 22674708 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopaedic consultation
Number of subjects: 553
Study 22674708 — intervention group
Group type: COMPARATOR
Intervention: Waiting time characteristics
Number of subjects: 553
Study 19586154 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline scores of the situational temptations inventory
Number of subjects: 577
Study 19586154 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive/social temptation subscore
Number of subjects: 577
Study 19586154 — intervention group
Group type: EXPERIMENTAL
Intervention: Fagerstrom test of nicotine dependence
Number of subjects: 577
Study 19586154 — intervention group
Group type: EXPERIMENTAL
Intervention: Stages of change
Number of subjects: 577
Study 17605483 — intervention group
Group type: EXPERIMENTAL
Intervention: External bleaching treatment (bleaching gel for 60 minutes, followed by in-office bleaching and 2-week home bleaching for 1 hour daily)
Number of subjects: 10
Study 17605483 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire on patient satisfaction
Number of subjects: 10
Study 15843228 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress doses of hydrocortisone (100 mg loading dose followed by continuous infusion of 0.18 mg/kg/h for 6 days)
Number of subjects: 24
Study 15843228 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress doses of hydrocortisone
Number of subjects: 24
Study 12028309 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrosurgical pulpotomy
Number of subjects: 50
Study 12028309 — intervention group
Group type: COMPARATOR
Intervention: Formocresol pulpotomy
Number of subjects: 50
Study 9457193 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrow-Trerotola percutaneous thrombolytic device (PTD)
Number of subjects: 122
Study 9457193 — intervention group
Group type: COMPARATOR
Intervention: Pulse-spray pharmacomechanical thrombolysis (PSPMT)
Number of subjects: 122
Study 7823364 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical rhPDGF‐BB (2.2 micrograms/cm2 of ulcer area)
Number of subjects: 118
Study 7823364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 7823364 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical rhPDGF‐BB
Number of subjects: 118
Study 7823364 — intervention group
Group type: COMPARATOR
Intervention: Topical rhPDGF‐BB and Placebo
Number of subjects: 118
Study 2248812 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. ketorolac trometamol 30 mg
Number of subjects: 100
Study 2248812 — intervention group
Group type: COMPARATOR
Intervention: morphine sulphate 10 mg
Number of subjects: 100
Study 7309298 — intervention group
Group type: EXPERIMENTAL
Intervention: SROC 160 (160 mg oxprenolol slow-release + 20 mg chlorthalidone once daily)
Number of subjects: 103
Study 7309298 — intervention group
Group type: COMPARATOR
Intervention: COC 80 (80 mg oxprenolol + 10 mg chlorthalidone twice daily)
Number of subjects: 103
Study 30657033 — intervention group
Group type: EXPERIMENTAL
Intervention: C. spinosa oxymel (10 mL/thrice daily for 3 months)
Number of subjects: 30
Study 30657033 — intervention group
Group type: EXPERIMENTAL
Intervention: C. spinosa oxymel
Number of subjects: 30
Study 30657033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30657033 — intervention group
Group type: COMPARATOR
Intervention: Simple oxymel
Number of subjects: 30
Study 29102985 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided real GN pulsed radiofrequency
Number of subjects: 142
Study 29102985 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided sham GN pulsed radiofrequency (placebo)
Number of subjects: 142
Study 26238226 — intervention group
Group type: EXPERIMENTAL
Intervention: NYU Caregiver Intervention for Adult Children (NYUCI‐AC)
Number of subjects: 107
Study 26238226 — intervention group
Group type: COMPARATOR
Intervention: Contact control group
Number of subjects: 107
Study 24158337 — intervention group
Group type: EXPERIMENTAL
Intervention: Group IM (immediately loaded implants)
Number of subjects: 40
Study 24158337 — intervention group
Group type: COMPARATOR
Intervention: Group NL (nonloaded implants)
Number of subjects: 40
Study 22087576 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat training with whole-body vibration
Number of subjects: 23
Study 22087576 — intervention group
Group type: COMPARATOR
Intervention: Squat training without vibration
Number of subjects: 23
Study 19178789 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat rice pudding
Number of subjects: 40
Study 19178789 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate rice pudding
Number of subjects: 40
Study 19178789 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste condition
Number of subjects: 40
Study 19178789 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal condition
Number of subjects: 40
Study 19178789 — intervention group
Group type: EXPERIMENTAL
Intervention: Fullness condition
Number of subjects: 40
Study 19178789 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction condition
Number of subjects: 40
Study 17989948 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrosome wound gel
Number of subjects: 47
Study 17989948 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream
Number of subjects: 47
Study 15086213 — intervention group
Group type: EXPERIMENTAL
Intervention: octreotide 200 microg tid
Number of subjects: 36
Study 15086213 — intervention group
Group type: EXPERIMENTAL
Intervention: octreotide 500 microg tid
Number of subjects: 36
Study 11265037 — intervention group
Group type: EXPERIMENTAL
Intervention: RAB-plate
Number of subjects: 218
Study 11265037 — intervention group
Group type: COMPARATOR
Intervention: Sliding hip screw
Number of subjects: 218
Study 9590459 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparse sampling method (7 blood samples)
Number of subjects: 50
Study 9590459 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited sampling model (LSM) using samples from 10 subjects at 6 and 8 hours
Number of subjects: 50
Study 9590459 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparse sampling method
Number of subjects: 50
Study 9590459 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited sampling model (LSM)
Number of subjects: 50
Study 7834260 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency electroconvulsive therapy (ECT)
Number of subjects: 0
Study 7834260 — intervention group
Group type: COMPARATOR
Intervention: Unilateral ECT
Number of subjects: 0
Study 7834260 — intervention group
Group type: COMPARATOR
Intervention: Bilateral ECT
Number of subjects: 0
Study 3605315 — intervention group
Group type: EXPERIMENTAL
Intervention: GCS
Number of subjects: 12
Study 3605315 — intervention group
Group type: COMPARATOR
Intervention: GCS‐O/O
Number of subjects: 12
Study 3605315 — intervention group
Group type: COMPARATOR
Intervention: NO‐GCS
Number of subjects: 12
Study 28581366 — intervention group
Group type: EXPERIMENTAL
Intervention: Lying-flat positioning
Number of subjects: 94
Study 28581366 — intervention group
Group type: COMPARATOR
Intervention: Upright head positioning
Number of subjects: 94
Study 28581366 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 94
Study 28233128 — intervention group
Group type: EXPERIMENTAL
Intervention: 1210-nm laser treatment on one breast
Number of subjects: 40
Study 28233128 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated breast)
Number of subjects: 40
Study 28233128 — intervention group
Group type: EXPERIMENTAL
Intervention: 1210-nm laser treatment
Number of subjects: 40
Study 25540029 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L index score
Number of subjects: 289
Study 25540029 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 289
Study 25540029 — intervention group
Group type: COMPARATOR
Intervention: EQ-5D-3L index score
Number of subjects: 289
Study 22281786 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily (Group A, 30 patients)
Number of subjects: 60
Study 22281786 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg every other day (Group B, 30 patients)
Number of subjects: 60
Study 20585269 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy
Number of subjects: 49
Study 20585269 — intervention group
Group type: COMPARATOR
Intervention: Shapedown (control)
Number of subjects: 49
Study 17354119 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (15 mg, oral)
Number of subjects: 10
Study 17354119 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (30 mg, oral)
Number of subjects: 10
Study 17354119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 16297033 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw and tongue movements
Number of subjects: 10
Study 16297033 — intervention group
Group type: COMPARATOR
Intervention: Hand extension
Number of subjects: 10
Study 16297033 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral movement
Number of subjects: 10
Study 12084605 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 2.5 mg
Number of subjects: 369
Study 12084605 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 10 mg
Number of subjects: 369
Study 12084605 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 20 mg
Number of subjects: 369
Study 12084605 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 40 mg
Number of subjects: 369
Study 12084605 — intervention group
Group type: COMPARATOR
Intervention: Control (2.5 mg)
Number of subjects: 369
Study 9470006 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk
Number of subjects: 88
Study 9470006 — intervention group
Group type: COMPARATOR
Intervention: Milk preparation (skimmed milk enriched with oleic acid)
Number of subjects: 88
Study 8592957 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI; n = 8)
Number of subjects: 26